Conclusion VAM regime is a practical and effective second-line chemotherapy for patients with ovarian carcinoma refractory to platinum based chemothrapy.

• 结论VAM方案是当前国内治疗耐铂卵巢癌切实可行的有效方案，值得推广应用。